Galapagos NV
GLPG
#4981
Rank
ยฃ1.40 B
Marketcap
ยฃ20.86
Share price
0.00%
Change (1 day)
0.36%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of March 2026 : ยฃ2.93 Billion

According to Galapagos NV's latest financial reports the company's total assets are ยฃ2.93 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2026)

Total assets by year

Year Total assets Change
2024-12-31ยฃ3.42 B-9.3%
2023-12-31ยฃ3.78 B-9.93%
2022-12-31ยฃ4.19 B-3.66%
2021-12-31ยฃ4.35 B-15.55%
2020-12-31ยฃ5.15 B-0.48%
2019-12-31ยฃ5.18 B299.62%
2018-12-31ยฃ1.29 B13.61%
2017-12-31ยฃ1.14 B23.65%
2016-12-31ยฃ0.92 B182.85%
2015-12-31ยฃ0.32 B54.53%
2014-12-31ยฃ0.21 B-12.18%
2013-12-31ยฃ0.24 B24.92%
2012-12-31ยฃ0.19 B43.12%
2011-12-31ยฃ0.13 B-19.48%
2010-12-31ยฃ0.16 B31.35%
2009-12-31ยฃ0.12 B12.26%
2008-12-31ยฃ0.11 B3.69%
2007-12-31ยฃ0.10 B-3.21%
2006-12-31ยฃ0.11 B101.56%
2005-12-31ยฃ56.02 M407.88%
2004-12-31ยฃ11.03 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ151.15 B 5,046.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ83.08 B 2,729.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ102.67 B 3,396.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ111.49 B 3,696.20%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ96.82 B 3,196.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ85.78 B 2,820.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ62.64 B 2,033.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
ยฃ0.13 B-95.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ30.12 B 925.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel